Christina Yap

Latest

• A Phase II Clinical Trial Design for Associated Co-primary Efficacy and Toxicity Outcomes with Baseline Covariates
• How to design a dose-finding study using the continual reassessment method
• Combination Lenalidomide and Azacitidine - A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
• Implementing the EffTox dose-finding design in the Matchpoint trial